Detalles de la búsqueda
1.
Epidemiological and Clinical History of Viral Hepatitis in Korea / 감염과화학요법
Infection and Chemotherapy
; : 159-165, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-898634
2.
Epidemiological and Clinical History of Viral Hepatitis in Korea / 감염과화학요법
Infection and Chemotherapy
; : 159-165, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-890930
3.
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
Clinical and Molecular Hepatology
; : 295-304, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-897663
4.
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
Clinical and Molecular Hepatology
; : 295-304, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-889959
5.
Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
Gut and Liver
; : 117-127, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-874578
6.
Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
Gut and Liver
; : 420-429, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-898458
7.
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
Journal of Korean Medical Science
; : e105-2021.
Artículo
en Inglés
| WPRIM | ID: wpr-892153
8.
Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials
Gut and Liver
; : 895-903, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-914355
9.
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
Journal of Korean Medical Science
; : e105-2021.
Artículo
en Inglés
| WPRIM | ID: wpr-899857
10.
Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
Gut and Liver
; : 420-429, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-890754
11.
Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
Clinical and Molecular Hepatology
; : 125-135, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-874454
12.
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial
Clinical and Molecular Hepatology
; : 346-359, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-897659
13.
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial
Clinical and Molecular Hepatology
; : 346-359, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-889955
14.
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
Yonsei Medical Journal
; : 12-20, 2021.
Artículo
en Inglés
| WPRIM | ID: wpr-875607
15.
Rapid review of early status of COVID-19 infection in South Korea
Journal of the Korean Medical Association
; : 504-511, 2020.
Artículo
| WPRIM | ID: wpr-834738
16.
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
Clinical and Molecular Hepatology
; : 24-32, 2020.
Artículo
| WPRIM | ID: wpr-832238
17.
Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
Journal of Korean Medical Science
; : e104-2020.
Artículo
| WPRIM | ID: wpr-831503
18.
Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
Gut and Liver
; : 626-635, 2020.
Artículo
| WPRIM | ID: wpr-833184
19.
The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
Gut and Liver
; : 765-774, 2020.
Artículo
en Inglés
| WPRIM | ID: wpr-833171
20.
Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
Gut and Liver
; : 477-485, 2020.
Artículo
| WPRIM | ID: wpr-833120